Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 2212

Страница 1 из 222

Adjuvants of influenza vaccines: New possibilities of using sulphated polysaccharides from marine brown algae [аДЪЮВаНТЫ ГРИППОЗНЫХ ВакЦИН: НОВЫЕ ВОЗМОжНОСТИ ПРИМЕНЕНИЯ СУЛЬФаТИРОВаННЫХ ПОЛИСаХаРИДОВ ИЗ МОРСкИХ БУРЫХ ВОДОРОСЛЕЙ], polyoxidonium, sovidone) included in the licensed influenza vaccine. The main mechanisms of adjuvant action

Immunogenicity and safety of a trivalent subunit immunoadjuvant influenza vaccine in children with type 1 diabetes: Results of a prospective comparative study included children with T1D at the age from 3 to 17 years vaccinated against influenza by a trivalent

Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activityThe influenza vaccine Grippol® Quadrivalent (GQ) is a new vaccine, containing the adjuvant

HUMORAL IMMUNITY IN ELDERLY PERSONS VACCINATED AGAINST INFLUENZA SHORTLY BEFORE CANCELLATION OF COVID-19 PANDEMIC; [СОСТОЯНИЕ ГУМОРАЛЬНОГО ИММУНИТЕТА У ПОЖИЛЫХ, ПРИВИТЫХ ПРОТИВ ГРИППА НАКАНУНЕ ОТМЕНЫ СТАТУСА ПАНДЕМИИ COVID-19] group, high-dose or adjuvanted influenza vaccines are potentially more effective in terms

An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/ 05) influenza vaccine is safe and immunogenic in a single dose in humans of hemagglutinin [HA]) of a whole-virion inactivated prepandemic influenza vaccine adjuvanted with aluminum

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccineDuring the past decade, a number of H5 subtype influenza vaccines have been developed and tested

LEVEL OF INFLUENZA VIRUS STRAIN ANTIBODIES IN HEALTHY VACCINATED PEOPLE AT THE END OF THE COVID-19 PANDEMIC; [УРОВЕНЬ АНТИТЕЛ К ШТАММАМ ВИРУСА ГРИППА У ЗДОРОВЫХ ВАКЦИНИРОВАННЫХ НА ЭТАПЕ ЗАВЕРШЕНИЯ ПАНДЕМИИ COVID-19] of 123 healthy volunteers immunized with influenza quadrivalent inactivated subunit adjuvanted vaccine

Effect of Molecular Weight and Degree of Acetylation on Adjuvantive Properties of Chitosan Derivatives of acetylation (from 1 to 25 mol%) that were used as adjuvants in inactivated poliomyelitic, influenza, and live

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency the immunogenicity. However, the use of adjuvants for the development of quadrivalent inactivated influenza vaccines

Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors target for the development of a universal vaccine against influenza because M2e sequences are highly

Страница 1 из 222